ERBB2 and neoplasm: Among LumA-assigned cases, admixture was associated with slightly higher estrogen receptor positivity but lower progesterone receptor (PR) positivity and estrogen receptor–related gene expression and higher HER2 positivity, tumor size, grade, and tumor–node–metastasis stage.